Ambev S.A. reported BRL 88.2B of revenue over the trailing twelve months, −1.4% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: BRL 88.2B (to FY2025). Net income: BRL 15.5B, trailing twelve months to FY2025. Free cash flow: BRL 19.9B, trailing twelve months to FY2025. Operating margin: 26%, trailing twelve months to FY2025.

ABEVAmbev S.A.

Consumer Defensive

$3.20+40% 1Y

$3.20

$2.1052 weeks$3.42

ABEV as reported

Ambev S.A. reported BRL 88.2B of revenue over the trailing twelve months, −1.4% on the year before. 10 reported series are charted on this page, each one as filed.

BRL 88.2B

Revenue, trailing twelve months · to FY2025 · −1.4% against the twelve months before

Net income: BRL 15.5B
Net income · +7.4% year on year · trailing twelve months to FY2025
Free cash flow: BRL 19.9B
Free cash flow · −7.0% year on year · trailing twelve months to FY2025
Operating margin: 26%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for ABEV, trailing twelve months
Series	Latest	Year on year	As of
Revenue	BRL 88.2B	−1.4%	FY2025
Net income	BRL 15.5B	+7.4%	FY2025
EPS	BRL 0.99	+8.3%	FY2025
Gross margin	51%	n/a	FY2025
Operating margin	26%	n/a	FY2025
Net margin	18%	n/a	FY2025
ROE	18%	n/a	FY2025
ROA	11%	n/a	FY2025
ROIC	29%	n/a	FY2025
Free cash flow	BRL 19.9B	−7.0%	FY2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.